Excelsior Medical Co Ltd
Excelsior Medical Co., Ltd., together with its subsidiaries, sells medical supplies and equipment, medicines, and home medical devices in Taiwan, Hong Kong, China, the Philippines, Malaysia, and Indonesia. It operates in four segments: Excelsior, Dynamic, Arich, and Other. The company offers hemodialysis/plasma exchange; blood bags; artificial stomas; and health appliances. It is also involved in… Read more
Excelsior Medical Co Ltd (4104) - Total Assets
Latest total assets as of September 2025: NT$18.80 Billion TWD
Based on the latest financial reports, Excelsior Medical Co Ltd (4104) holds total assets worth NT$18.80 Billion TWD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Excelsior Medical Co Ltd - Total Assets Trend (2002–2024)
This chart illustrates how Excelsior Medical Co Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Excelsior Medical Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Excelsior Medical Co Ltd's total assets of NT$18.80 Billion consist of 60.0% current assets and 40.0% non-current assets.
| Asset Category | Amount (TWD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | NT$0.00 | 20.6% |
| Accounts Receivable | NT$5.61 Billion | 27.5% |
| Inventory | NT$1.39 Billion | 6.8% |
| Property, Plant & Equipment | NT$0.00 | 0.0% |
| Intangible Assets | NT$18.18 Million | 0.1% |
| Goodwill | NT$28.95 Million | 0.1% |
Asset Composition Trend (2002–2024)
This chart illustrates how Excelsior Medical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Excelsior Medical Co Ltd's current assets represent 60.0% of total assets in 2024, an increase from 0.0% in 2002.
- Cash Position: Cash and equivalents constituted 20.6% of total assets in 2024, up from 5.5% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2002.
- Asset Diversification: The largest asset category is accounts receivable at 27.5% of total assets.
Excelsior Medical Co Ltd Competitors by Total Assets
Key competitors of Excelsior Medical Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
C.Q. Pharmaceutical Holding Co Ltd
SHE:000950
|
China | CN¥67.71 Billion |
|
Shenzhen Glory Medical Co Ltd
SHE:002551
|
China | CN¥3.56 Billion |
|
Shandong Realcan Pharmaceutical Co Ltd
SHE:002589
|
China | CN¥15.33 Billion |
|
Hanmi Science
KO:008930
|
Korea | ₩1.45 Trillion |
|
BCM Alliance Bhd
KLSE:0187
|
Malaysia | RM147.86 Million |
|
Qingdao Baheal Medical INC.
SHE:301015
|
China | CN¥7.59 Billion |
|
CHC Healthcare Group
TW:4164
|
Taiwan | NT$14.83 Billion |
|
China Meheco Co Ltd
SHG:600056
|
China | CN¥36.99 Billion |
Excelsior Medical Co Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Excelsior Medical Co Ltd generates 0.42x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Excelsior Medical Co Ltd generates $ 3.79 in net profit.
Excelsior Medical Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.63 | 1.34 | 2.11 |
| Quick Ratio | 1.41 | 1.21 | 1.90 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | NT$4.02 Billion | NT$ 3.49 Billion | NT$ 4.48 Billion |
Excelsior Medical Co Ltd - Advanced Valuation Insights
This section examines the relationship between Excelsior Medical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.65 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 12.7% |
| Total Assets | NT$20.37 Billion |
| Market Capitalization | $236.51 Million USD |
Valuation Analysis
Below Book Valuation: The market values Excelsior Medical Co Ltd's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Excelsior Medical Co Ltd's assets grew by 12.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Excelsior Medical Co Ltd (2002–2024)
The table below shows the annual total assets of Excelsior Medical Co Ltd from 2002 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | NT$20.37 Billion | +12.66% |
| 2023-12-31 | NT$18.08 Billion | +9.69% |
| 2022-12-31 | NT$16.48 Billion | +9.12% |
| 2021-12-31 | NT$15.11 Billion | +7.86% |
| 2020-12-31 | NT$14.00 Billion | +1.74% |
| 2019-12-31 | NT$13.76 Billion | -1.54% |
| 2018-12-31 | NT$13.98 Billion | -6.49% |
| 2017-12-31 | NT$14.95 Billion | -11.14% |
| 2016-12-31 | NT$16.83 Billion | +7.75% |
| 2015-12-31 | NT$15.62 Billion | +4.92% |
| 2014-12-31 | NT$14.88 Billion | +4.87% |
| 2013-12-31 | NT$14.19 Billion | +8.42% |
| 2012-12-31 | NT$13.09 Billion | +4.62% |
| 2011-12-31 | NT$12.51 Billion | +7.03% |
| 2010-12-31 | NT$11.69 Billion | +27.96% |
| 2009-12-31 | NT$9.14 Billion | +91.40% |
| 2008-12-31 | NT$4.77 Billion | +1.56% |
| 2007-12-31 | NT$4.70 Billion | +18.75% |
| 2006-12-31 | NT$3.96 Billion | -0.84% |
| 2005-12-31 | NT$3.99 Billion | +4.19% |
| 2004-12-31 | NT$3.83 Billion | +34.13% |
| 2003-12-31 | NT$2.86 Billion | +39.75% |
| 2002-12-31 | NT$2.04 Billion | -- |